Immunome, Inc.
(NASDAQ: IMNM)

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

19.814

-0.276 (-1.37%)
Range 19.760 - 20.200   (2.23%)
Open 20.080
Previous Close 20.090
Bid Price 5.440
Bid Volume 9
Ask Price 5.890
Ask Volume 8
Volume 45,500
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:06.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis